PRAME peptide (425-433)
PRAME peptide (425-433) is a peptide corresponding to amino acids 425-433 of PRAME (preferentially expressed antigen) in melanoma. PRAME peptide (425-433) can be used to stimulate human PRAME-specific CD8+ T cells.
For research use only. We do not sell to patients.
- CAS No.: 329314-98-9
- Formula: C46H80N12O12
- Molecular Weight:993.20
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 329314-98-9
-
Molecular Weight 993.20
-
Formula C46H80N12O12
-
Sequence
Ser-Leu-Leu-Gln-His-Leu-Ile-Gly-Leu
-
Sequence Shortening
SLLQHLIGL
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Spel L, et al. Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma. Oncotarget. 2015 Nov 3;6(34):35770-81. [Content Brief]
[2]. Weber JS, et al. A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother. 2011 Sep;34(7):556-67. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)